Two Sigma Investments’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $84.2M | Buy |
1,051,535
+660,149
| +169% | +$54.4M | 0.07% | 323 |
|
|
2025
Q4 | $33.4M | Buy |
391,386
+319,186
| +442% | +$26.2M | 0.05% | 495 |
|
|
2025
Q3 | $5.61M | Buy |
72,200
+17,837
| +33% | +$1.39M | 0.01% | 1360 |
|
|
2025
Q2 | $4.25M | Sell |
54,363
-42,740
| -44% | -$3.19M | 0.01% | 1327 |
|
|
2025
Q1 | $7.04M | Sell |
97,103
-27,929
| -22% | -$2M | 0.02% | 944 |
|
|
2024
Q4 | $9.26M | Buy |
125,032
+50,463
| +68% | +$3.53M | 0.02% | 790 |
|
|
2024
Q3 | $4.92M | Sell |
74,569
-77,444
| -51% | -$5.63M | 0.01% | 1100 |
|
|
2024
Q2 | $14M | Buy |
152,013
+22,300
| +17% | +$1.97M | 0.03% | 581 |
|
|
2024
Q1 | $12.4M | Sell |
129,713
-1,032,317
| -89% | -$86.7M | 0.03% | 579 |
|
|
2023
Q4 | $88.6M | Sell |
1,162,030
-141,235
| -11% | -$9.83M | 0.2% | 130 |
|
|
2023
Q3 | $90.3M | Buy |
1,303,265
+458,350
| +54% | +$36.8M | 0.24% | 107 |
|
|
2023
Q2 | $79.7M | Sell |
844,915
-750,809
| -47% | -$65.3M | 0.2% | 142 |
|
|
2023
Q1 | $132M | Sell |
1,595,724
-1,472,202
| -48% | -$116M | 0.38% | 62 |
|
|
2022
Q4 | $229M | Buy |
3,067,926
+1,921,433
| +168% | +$148M | 0.72% | 14 |
|
|
2022
Q3 | $94.7M | Buy |
1,146,493
+611,998
| +115% | +$58.9M | 0.32% | 77 |
|
|
2022
Q2 | $50.8M | Buy |
534,495
+270,205
| +102% | +$28M | 0.17% | 156 |
|
|
2022
Q1 | $31.1M | Sell |
264,290
-847,527
| -76% | -$95.1M | 0.09% | 277 |
|
|
2021
Q4 | $144M | Sell |
1,111,817
-264,432
| -19% | -$30.8M | 0.31% | 75 |
|
|
2021
Q3 | $156M | Buy |
1,376,249
+160,624
| +13% | +$18.3M | 0.35% | 60 |
|
|
2021
Q2 | $126M | Buy |
1,215,625
+412,075
| +51% | +$38.8M | 0.29% | 69 |
|
|
2021
Q1 | $67.2M | Buy |
+803,550
| New | +$67.9M | 0.17% | 119 |
|
|
2020
Q3 | – | Sell |
-480,521
| Closed | -$37.5M | – | 3219 |
|
|
2020
Q2 | $33.2M | Buy |
480,521
+57,797
| +14% | +$4.11M | 0.16% | 130 |
|
|
2020
Q1 | $26.6M | Sell |
422,724
-1,249,935
| -75% | -$90.1M | 0.22% | 86 |
|
|
2019
Q4 | $130M | Buy |
1,672,659
+1,579,452
| +1,695% | +$123M | 0.39% | 48 |
|
|
2019
Q3 | $6.83M | Buy |
+93,207
| New | +$6.55M | 0.02% | 714 |
|
|
2018
Q4 | – | Sell |
-38,568
| Closed | -$2.24M | – | 3132 |
|
|
2018
Q3 | $2.24M | Sell |
38,568
-241,269
| -86% | -$11.8M | 0.01% | 1398 |
|
|
2018
Q2 | $13.6M | Sell |
279,837
-1,007,595
| -78% | -$47M | 0.04% | 546 |
|
|
2018
Q1 | $59.9M | Sell |
1,287,432
-838,500
| -39% | -$36.4M | 0.2% | 127 |
|
|
2017
Q4 | $79.9M | Buy |
2,125,932
+1,764,444
| +488% | +$64.8M | 0.26% | 92 |
|
|
2017
Q3 | $13.2M | Buy |
+361,488
| New | +$13.8M | 0.05% | 431 |
|
|
2016
Q4 | – | Sell |
-1,706,223
| Closed | -$68.6M | – | 3212 |
|
|
2016
Q3 | $68.6M | Sell |
1,706,223
-685,233
| -29% | -$25.8M | 0.25% | 89 |
|
|
2016
Q2 | $79.5M | Buy |
2,391,456
+1,810,809
| +312% | +$62M | 0.34% | 61 |
|
|
2016
Q1 | $17.1M | Sell |
580,647
-1,792,080
| -76% | -$49.4M | 0.08% | 291 |
|
|
2015
Q4 | $62.5M | Buy |
+2,372,727
| New | +$61.6M | 0.3% | 81 |
|
|
2015
Q2 | – | Sell |
-3,027,510
| Closed | -$68.3M | – | 2873 |
|
|
2015
Q1 | $71.9M | Sell |
3,027,510
-276,744
| -8% | -$6.21M | 0.34% | 54 |
|
|
2014
Q4 | $70.1M | Sell |
3,304,254
-1,468,380
| -31% | -$29.5M | 0.39% | 42 |
|
|
2014
Q3 | $81.3M | Buy |
4,772,634
+4,219,332
| +763% | +$66.6M | 0.36% | 75 |
|
|
2014
Q2 | $7.92M | Sell |
553,302
-377,910
| -41% | -$5.12M | 0.04% | 558 |
|
|
2014
Q1 | $11.5M | Sell |
931,212
-2,236,890
| -71% | -$25.8M | 0.06% | 400 |
|
|
2013
Q4 | $34.7M | Sell |
3,168,102
-102,642
| -3% | -$1.16M | 0.19% | 142 |
|
|
2013
Q3 | $38M | Buy |
+3,270,744
| New | +$38.3M | 0.24% | 105 |
|
Other funds holding EW
VCM
VPM
Two Sigma Investments's EW Position: Q1 2026 in Review
Two Sigma Investments increased its Edwards Lifesciences (EW) stake by 169% in Q1 2026, buying an estimated $54.4M and bringing the position to 1,051,535 shares worth $84.2M. The position accounts for 0.07% of the portfolio, ranked #323.
Two Sigma Investments first reported a position in EW in Q3 2013 and has held it in 41 quarters since. The position peaked at $229M in Q4 2022. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.
- Two Sigma Investments held 1,051,535 shares of Edwards Lifesciences worth $84.2M as of Q1 2026.
- Two Sigma Investments bought 660,149 Edwards Lifesciences shares in Q1 2026, an estimated $54.4M.
- Edwards Lifesciences made up 0.07% of Two Sigma Investments's portfolio in Q1 2026, its #323 holding.
- Two Sigma Investments first reported a position in Edwards Lifesciences in Q3 2013 and has held it in 41 quarters since.
- Two Sigma Investments's Edwards Lifesciences position peaked at $229M in Q4 2022.
- 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.
Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.